Francesca Pasinelli (Gardone Val Trompia – Brescia, 1960) has been an independent Director of CIR from June 2020.
She was an independent board member of CIR (before the merger with COFIDE) from 2018 to 2019.
She has been the General Manager and a board member of Fondazione Telethon since 2009.
She was the General Manager of Dompé Q-rare, a division of Dompé S.p.A., from 2007 to 2009. Previously, she was the scientific director of Fondazione Telethon, Division head at Schering Plough S.p.A. and held various managerial roles at Smith Kline Beecham S.p.A. and Glaxo S.p.A..
She is on the board of directors of the following listed companies: Anima Holding S.p.A. and Diasorin S.p.A.. She is also on the Board of Anima SGR, Anima Alternative SGR and Dompè Farmaceutici S.p.A., and is a member of the Executive Committee of the Istituto Italiano di Tecnologia (IIT) in Genoa.
She is a Commander of the Order of Merit of the Italian Republic and a Grand Officer of Merit of the Italian Republic.
She holds a degree in Pharmacology from the University of Parma and specialized in Pharmacology at the University of Milan.